Medical interventions for fungal keratitis

Cochrane Database of Systematic Reviews

Volumn 2015, Issue 4, 2015, Pages

  Florcruz, Nilo Vincent ^a   Evans, Jennifer R ^b  

^a UNIVERSITY OF THE PHILIPPINES   (Philippines)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; AMPHOTERICIN B DEOXYCHOLATE; CHLORHEXIDINE GLUCONATE; ECONAZOLE; FLUCONAZOLE; ITRACONAZOLE; MICONAZOLE; NATAMYCIN; SULFADIAZINE SILVER; VORICONAZOLE; ANTIFUNGAL AGENT;

ANTERIOR STAPHYLOMA; BEST CORRECTED VISUAL ACUITY; CATARACT; CONJUNCTIVA DISEASE; CONJUNCTIVAL HEMORRHAGE; CONJUNCTIVAL NECROSIS; CORNEA EDEMA; CORNEA PERFORATION; ENDOPHTHALMITIS; EYE DISEASE; GLAUCOMA; HUMAN; INTRAOCULAR PRESSURE ABNORMALITY; KERATOMYCOSIS; PANOPHTHALMITIS; PENETRATING KERATOPLASTY; PHTHISIS BULBI; PHTHSIS BULBI; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SYSTEMATIC REVIEW; SYSTEMIC DISEASE; TEMPORARY PUNCTATE EPITHELIOPATHY; TREATMENT OUTCOME; TREATMENT RESPONSE; EYE INFECTIONS, FUNGAL; KERATITIS; META ANALYSIS; MICROBIOLOGY;

ANTIFUNGAL AGENTS; EYE INFECTIONS, FUNGAL; HUMANS; KERATITIS; NATAMYCIN; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VORICONAZOLE;

EID: 84944462932     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD004241.pub4     Document Type: Review

References (62)

1. Agarwal PK, Roy P, Das A, Banerjee A, Maity PK, Banerjee AR. Efficacy of topical and systemic itraconazole as a broad-spectrum antifungal agent in mycotic corneal ulcer. A preliminary study. Indian Journal of Ophthalmology 2001;49(3):173-6.
2. Arora R, Gupta D. Voriconazole versus natamycin as primary treatment in fungal ulcers. Clinical and Experimental Ophthalmology 2011;39(5):434-40.
3. Basak SK, Mahanta A, Bhowmick A, Bhattacharya D. Intracameral amphotericin B in deep keratomycosis with hypopyon: a randomized controlled clinical trial. American Academy of Ophthalmology 2004:176.
4. Mahdy RA, Nada WM, Wageh MM. Topical amphotericin B and subconjunctival injection of fluconazole (combination therapy) versus topical amphotericin B (monotherapy) in treatment of keratomycosis. Journal of Ocular Pharmacology and Therapeutics 2010;26(3):281-5.
5. Mohan M, Gupta SK, Kalra VK, Vajpayee RB, Sachdev MS. Silver sulphadiazine in the treatment of mycotic keratitis. Indian Journal of Medical Research 1987;85:572-5.
6. Lalitha P, Sun CQ, Prajna NV, Karpagam R, Geetha M, O'Brien KS, et al. In vitro susceptibility of filamentous fungal isolates from a corneal ulcer clinical trial. American Journal of Ophthalmology 2014;157(2):318-26.
7. Prajna NV, Krishnan T, Mascarenhas J, Rajaraman R, Prajna L, Srinivasan M, et al. The mycotic ulcer treatment trial: a randomized trial comparing natamycin vs voriconazole. JAMA Ophthalmology 2013;131(4):422-9.
8. Prajna NV, Srinivasan M, Lalitha P, Krishnan T, Rajaraman R, Ravindran M, et al. Differences in clinical outcomes in keratitis due to fungus and bacteria. JAMA Ophthalmology 2013;131(8):1088-9.
9. Sun CQ, Prajna NV, Krishnan T, Mascarenhas J, Rajaraman R, Srinivasan M, et al. Expert prior elicitation and Bayesian analysis of the Mycotic Ulcer Treatment Trial I. Investigative Ophthalmology and Visual Science 20103;54(6):4167-73.
10. Parchand S, Gupta A, Ram J, Gupta N, Chakrabarty A. Voriconazole for fungal corneal ulcers. Ophthalmology 2012;119(5):1083.
11. Prajna NV, John RK, Nirmalan PK, Lalitha P, Srinivasan M. A randomised clinical trial comparing 2% econazole and 5% natamycin for the treatment of fungal keratitis. British Journal of Ophthalmology 2003;87(10):1235-7.
12. Krishnan T, Prajna NV, Gronert K, Oldenburg CE, Ray KJ, Keenan JD, et al. Gender differences in re-epithelialisation time in fungal corneal ulcers. British Journal of Ophthalmology 2012;96(1):137-8.
13. Lalitha P, Prajna NV, Oldenburg CE, Srinivasan M, Krishnan T, Mascarenhas J, et al. Organism, minimum inhibitory concentration, and outcome in a fungal corneal ulcer clinical trial. Cornea 2012;31(6):662-7.
14. Prajna NV, Krishnan T, Mascarenhas J, Srinivasan M, Oldenburg CE, Toutain-Kidd CM, et al. Predictors of outcome in fungal keratitis. Eye 2012;26(9):1226-31.
15. Prajna NV, Lalitha PS, Mascarenhas J, Krishnan T, Srinivasan M, Vaitilingam CM, et al. Natamycin and voriconazole in Fusarium and Aspergillus keratitis: subgroup analysis of a randomised controlled trial. British Journal of Ophthalmology 2012;96(11):1440-1.
16. Prajna NV, Mascarenhas J, Krishnan T, Reddy PR, Prajna L, Srinivasan M, et al. Comparison of natamycin and voriconazole for the treatment of fungal keratitis. Archives of Ophthalmology 2010;128(6):672-8.
17. Rahman MR, Minassian DC, Srinivasan M, Martin MJ, Johnson GJ. Trial of chlorhexidine gluconate for fungal corneal ulcers. Ophthalmic Epidemiology 1997;4(3):141-9.
18. Rahman MR, Johnson GJ, Husain R, Howlader SA, Minassian DC. Randomised trial of 0.2% chlorhexidine gluconate and 2.5% natamycin for fungal keratitis in Bangladesh. British Journal of Ophthalmology 1998;82(8):919-25.
19. Sharma N, Chacko J, Velpandian T, Titiyal JS, Sinha R, Satpathy G, et al. Comparative evaluation of topical versus intrastromal voriconazole as an adjunct to natamycin in recalcitrant fungal keratitis. Ophthalmology 2013;120(4):677-81.
20. Chen TH, Li SW, Niu XX, Ning JH, Lu FQ, Guo ZF. Clinical study of domestic natamycin medication for the treatment of fungal corneal ulcer. International Eye Science 2013;13(2):356-8.
21. Gupta A, Ram J, Brar GS, Pandav SS. Early vs. late intracameral amphotericin B in nonresponding severe keratomycosis. American Academy of Ophthalmology 2006:220.
22. ISRCTN84613089. Intracameral voriconazole injection in the treatment of fungal endophthalmitis developed from keratitis. www.isrctn.com/ISRCTN84613089 (accessed 30 April 2013).
23. Jones BR. Principles in the management of oculomycosis. XXXI Edward Jackson memorial lecture. American Journal of Ophthalmology 1975;79(5):719-51.
24. Kalavathy CM, Thomas PA. Efficacy of topical and systemic itraconazole as a broad-spectrum antifungal agent in mycotic corneal ulcer. A preliminary study. Indian Journal of Ophthalmology 2002;50(1):71-2.
25. Kalavathy CM, Parmar P, Kaliamurthy J, Philip VR, Ramalingam MD, Jesudasan CA, et al. Comparison of topical itraconazole 1% with topical natamycin 5% for the treatment of filamentous fungal keratitis. Cornea 2005;24(4):449-52.
26. Lavingia B, Dave S. Comparative study of amphotericin-B pimaricin and gentian violet on ocular fungi. Indian Journal of Ophthalmology 1986;34:73-7.
27. Li QT. Clinical curative effect of irrigating the anterior chamber with solution of amphotericin B to treat the fungal keratitis. International Journal of Ophthalmology 2011;11(7):1194-6.
28. Mabon M. Fungal keratitis. International Ophthalmology Clinics 1998;38(4):115-23.
29. Mahashabde S, Nahata MC, Shrivastava U. A comparative study of anti-fungal drugs in mycotic corneal ulcer. Indian Journal of Ophthalmology 1987;35(5-6):149-52.
30. Maichuk I, Karimov MK, Lapshina NA. Ketoconazole in the treatment of ocular mycoses [Ketokonazol v lechenii mikozov glaza]. Vestnik Oftalmologii 1990;106(1):44-6.
31. Maichuk I, Lapshina NA, Diadina UV. Midazoles in the treatment of ocular mycoses [Imidazoly v lechenii mikozov glaza]. Antibiotiki i Khimioterapiia 1991;36(1):45-6.
32. Maichuk I, Diadina UV. Itraconazole in the treatment of ophthalmomycoses [Itrakonazol v lechenii oftal'momikozov]. Antibiotiki i Khimioterapiia 1994;39(7):54-6.
33. Maichuk I, Diadina UV. Metamphocin in the treatment of ocular mycoses [Metamfotsin v lechenii mikozov glaza]. Antibiotiki i Khimioterapiia 1995;40(11-12):55-6.
34. Martin MJ, Rahman MR, Johnson GJ, Srinivasan M, Clayton YM. Mycotic keratitis: susceptibility to antiseptic agents. International Ophthalmology 1996;19(5):299-302.
35. Mitsui Y, Kitano S, Uchida Y, Tanaka N, Kobayashi S, Tokuda H, et al. Effect of 1% pimaricin ophthalmic ointment in the treatment of keratomycosis. Nippon Ganka Gakkai Zasshi 1987;91(2):304-11.
36. Mohan M, Gupta SK, Kalra VK, Vajpayee RB, Sachdev MS. Topical silver sulphadiazine - a new drug for ocular keratomycosis. British Journal of Ophthalmology 1988;72(3):192-5.
37. NCT00516399. A clinical trial of the treatment of fungal corneal ulcers with povidone-iodine. ClinicalTrials.gov/show/NCT00516399 (accessed 20 Sept 2011).
38. Oude Lashof AM, Rothova A, Sobel JD, Ruhnke M, Pappas PG, Viscoli C, et al. Ocular manifestations of candidemia. Clinical Infectious Diseases 2011;53(3):262-8.
39. Panda A, Sharma N, Angra SK. Topical fluconazole therapy of Candida keratitis. Cornea 1996;15(4):373-5.
40. Rao SK, Madhavan HN, Rao G, Padmanabhan P. Fluconazole in filamentous fungal keratitis. Cornea 1997;16(6):700.
41. Ray A, Rao SK, Fogla R, Padmanabhan P, Kalavathy CM, Thomas PA, et al. Efficacy of topical and systemic itraconazole as a broad-spectrum antifungal agent in mycotic corneal ulcer. A preliminary study. Indian Journal of Ophthalmology 2002;50(1):70-2.
42. Reddy PR, Reddy PS, Reddy AR, Saboo NK. A comparative evaluation of nystatin, amphotericin-b and miconazole in keratomycosis. Indian Journal of Ophthalmology 1982;30(4):249-50.
43. Shuai SS, Ning HZ, Chen F, He XY, Yu QS. Clinical observation of povidone iodine combined with carbolic acid in the treatment of fungal corneal ulcer. International Eye Science 2012;12(12):2329-30.
44. Sun B, He Y, Wang Y. Comparison of various types of imidazole derivatives for treatment of filamentous fungal keratitis. Chung Hua Yen Ko Tsa Chih 1996;32(4):260-3.
45. Xie L, Dong X, Shi W. Treatment of fungal keratitis by penetrating keratoplasty. British Journal of Ophthalmology 2001;85(9):1070-4.
46. Qu XL, Zhao GQ, Gao A, Che CY, Lin J, Hu LT, et al. Efficacy observation of the fungal keratitis treated by the Natamycin and recombinant bovine basic fibroblast growth factor ophthalmic gel. International Eye Science 2013;13(7):1322-5.
47. CTRI/2011/091/000107. Evaluation of intracameral amphotericin B in the management of deep fungal keratitis:randomized controlled trial. www.ctri.nic.in/Clinicaltrials/pmaindet2.php?trialid=2625 (accessed 18 March 2015).
48. NCT00997035. Mycotic Ulcer Treatment Trial II. ClinicalTrials.gov/show/NCT00997035 (accessed 18 March 2015).
49. Galarreta DJ, Tuft SJ, Ramsay A, Dart JK. Fungal keratitis in London: microbiological and clinical evaluation. Cornea 2007;26(9):1082-6.
50. Glanville JM, Lefebvre C, Miles JN, Camosso-Stefinovic J. How to identify randomized controlled trials in MEDLINE: ten years on. Journal of the Medical Library Association 2006;94(2):130-6.
51. Gopinathan U, Garg P, Fernandes M, Sharma S, Athmanathan S, Rao GN. The epidemiological features and laboratory results of fungal keratitis: a 10 year review at a referral eye care center in South India. Cornea 2002;21(6):555-9.
52. Higgins J P, Thompson S G, Deeks J J, Altman D G. Measuring inconsistency in meta-analyses. BMJ 2003;327:557-60.
53. Higgins JPT, Altman DG, Sterne JAC (editors). Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 (updated March 2011). The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
54. Liesegang TJ, Forster RK. Spectrum of microbial keratitis in South Florida. American Journal of Ophthalmology 1980;90(1):38-47.
55. O' Brien TP, Rhee P. Pharmacotherapy of fungus infections of the eye. In: Zimmerman TJ, Koonere KS, Fecthner RD, Sharir M editor(s). Textbook of ocular pharmacology. Hagerstown: Lipincott-Raven, 1997:587-607.
56. O' Day D. Fungal keratitis. In: Pepose JS editor(s). Ocular infection and immunity. St Louis: Moseby, 1996:1048-61.
57. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014.
58. Tu EY, Park AJ. Recalcitrant Beauveria bassiana keratitis: confocal microscopy findings and treatment with posaconazole (Noxafil). Cornea 2007;26(8):1008-10.
59. Valenton M. Central microbial keratitis. Philippine Journal of Ophthalmology 2000;25(1):10-21.
60. FlorCruz NV, Peczon Jr, I. Medical interventions for fungal keratitis. Cochrane Database of Systematic Reviews 2003, Issue 2. [DOI: 10.1002/14651858.CD004241]
61. FlorCruz NV, Peczon IV. Medical interventions for fungal keratitis. Cochrane Database of Systematic Reviews 2008, Issue 1. [DOI: 10.1002/14651858.CD004241.pub2]
62. FlorCruz NV, Peczon IV, Evans JR. Medical interventions for fungal keratitis. Cochrane Database of Systematic Reviews 2012, Issue 2. [DOI: 10.1002/14651858.CD004241.pub3]